Clinical Trials Logo

Heart Diseases clinical trials

View clinical trials related to Heart Diseases.

Filter by:

NCT ID: NCT00005342 Completed - Obesity Clinical Trials

Weight Set-Point and HDL Concentration in Runners

Start date: May 1993
Phase: N/A
Study type: Observational

To investigate the differences in diet, fat cell morphology and lipoprotein metabolism in previously- overweight and naturally lean men and women who ran and who lived sedentary lifestyles in order to better understand the relationship between lipoprotein metabolism and weight set-point.

NCT ID: NCT00005340 Completed - Obesity Clinical Trials

Hypertension in Blacks of West African Origin

Start date: September 1991
Phase: N/A
Study type: Observational

To continue an international collaborative study on hypertension in populations of West African origin.

NCT ID: NCT00005338 Completed - Clinical trials for Cardiovascular Diseases

Homocysteine and Progression of Atherosclerosis

Start date: August 1991
Phase: N/A
Study type: Observational

In the first phase, to establish the relationship of progression of peripheral vascular disease (PVD) to plasma homocysteine. In the second phase, to conduct a randomized, controlled trial of folic acid treatment of plasma homocysteine in peripheral vascular disease.

NCT ID: NCT00005337 Completed - Clinical trials for Cardiovascular Diseases

Hostility and Coronary Risk--Role of Weak Vagal Function

Start date: April 1991
Phase: N/A
Study type: Observational

To determine whether deficient vagal antagonism of sympathetic nervous system (SNS) actions on the heart contributed to increased coronary heart disease risk in hostile persons.

NCT ID: NCT00005336 Completed - Clinical trials for Cardiovascular Diseases

Dietary Treatment of Hyperlipidemia in Women vs. Men

Start date: April 1991
Phase: N/A
Study type: Observational

To conduct a dietary intervention trial to test the lipid lowering response to the National Cholesterol Education Program (NCEP) Step Two Diet by free-living hyperlipidemic women and men and to compare the response between them.

NCT ID: NCT00005335 Completed - Clinical trials for Cardiovascular Diseases

Genetic Epidemiology of Lipoprotein-Lipid Levels

Start date: May 1991
Phase: N/A
Study type: Observational

To determine the contribution of polymorphic variation in candidate genes involved in lipid metabolism in determining quantitative lipoprotein-lipid levels and cardiovascular risk factors in Anglo and Hispanic populations of the San Luis Valley in southern Colorado. The candidate genes included those for A-IV, B, D, E, H, APO(a), LDL receptor, hepatic lipase, lipoprotein lipase, lethicin cholesterol acyletransferase (LCAT), and cholesteryl ester transfer protein.

NCT ID: NCT00005334 Completed - Depression Clinical Trials

Effects of Personality and Context on Recovery From Coronary Artery Bypass

Start date: July 1991
Phase: N/A
Study type: Observational

To study the personality and environmental factors that may determine the short-term and long-term sequelae of coronary artery bypass surgery (CABS).

NCT ID: NCT00005333 Completed - Hypertension Clinical Trials

Epidemic Hypertension in Nigerian Workers

Start date: January 1991
Phase: N/A
Study type: Observational

Originally from 1991 to 1991, to test the hypothesis that differences in hypertension prevalence in Nigerian workers were primarily related to differences in socioeconomic status (SES). At renewal in 1996, to determine the importance of weight gain and weight-related factors in blood pressure.

NCT ID: NCT00005332 Completed - Hypertension Clinical Trials

Antihypertensive Drug/Gene Interactions and CV Events

Start date: September 1991
Phase:
Study type: Observational

To investigate drug-gene interactions on the incidence of non-fatal myocardial infarction and stroke for hypertensive patients.

NCT ID: NCT00005331 Completed - Clinical trials for Cardiovascular Diseases

Providers for Smoking Prevention Programs

Start date: September 1988
Phase: N/A
Study type: Observational

To conduct a randomized controlled smoking prevention trial to evaluate quality of implementation and effectiveness, as a function of provider type (school teacher vs. nurse) and training (mediated vs. interactive).